Inside Innovation

A new CBRE report reveals that as the life science industry continues to boom in the Seattle area, companies are buying out lab space and

Omeros, a Seattle-based biotech company, has announced it is selling its Omidria franchise to Rayner Surgical Group. Omidria helps to prevent excessive pupil constriction in

The Association of Washington Business has named David Hojah, Entrepreneur of the Year. Hojah is the CEO and Founder of Parrots Inc., a Spokane-based medical

Tune Therapeutics, a new biotech company with roots in Seattle, has developed TEMPO, a epigenomic therapy platform. TEMPO can find epigenomic elements contributing to genetic

Aptevo Therapeutics, a Seattle-based biotech company, has seen a 46% rise in stock price per share as a result of positive data from its ongoing

A new wearable device used to detect opioid overdoses is under development at the University of Washington. The device would be able to detect an

Anavasi Diagnostics, a Washington-based startup, has received a total of $20.9 million in funding from the U.S. National Institutes of Health and individual investors to

The Allen Institute has launched a new division focused on exploring how the brain learns, memorizes and executes other complex actions. Karel Svoboda will be

If you enjoy spending time outdoors, Seattle is one of the best places in the U.S. to live and work, according to a recent SmartAsset

Thanks to a $20 million donation from Paul G Allen, late co-founder of Microsoft, Swedish Medical Services will be launching a research center focused on

Last week Absci celebrated the opening of its new headquarters, complete with 77,400 square feet of office and lab space. Washington state Governor Jay Inslee

Mozart Therapeutics has secured $55 million to develop celiac disease therapies. The Seattle-based biotech startup will use these funds for preclinical studies of the company’s